Jennison Associates LLC Novo Nordisk A S Call Options Transaction History
Jennison Associates LLC
- $167 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,742Shares Held
321MCall Options Held
13.7MPut Options Held
19.6M-
Bank Of America Corp Charlotte, NC14.7MShares$733 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$711 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$626 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$579 Million0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11MShares$548 Million0.31% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $112B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...